| Serial Number | 90364102 |
| Word Mark | ADARE PHARMA SOLUTIONS |
| Filing Date | Monday, December 7, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 15, 2022 |
| Registration Number | 6669722 |
| Registration Date | Tuesday, March 15, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 28, 2021 |
| Goods and Services | Manufacturing of pharmaceutical and nutritional and dietary formulations, to the specifications of others, used as facilitating agents for tablets, capsules, powders, injectables, suspensions, gels, liquids; Manufacturing services for others of drug delivery products for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic, nutritional or dietary agent; Manufacturing services for others of pharmaceutical and dietary compositions for use in veterinary administration forms such as tablets, capsules, suspensions, liquids; Manufacturing services for others of particles with specific particle dimension and narrow particle size distributions containing active ingredients |
| Description of Mark | The mark consists of the word "ADARE" with the second capital "A" in the word dissected in the middle by a circle located above the bottom half of the "A" and containing the top half of the "A", in triangle form, with the words "PHARMA SOLUTIONS" located directly below the word "ADARE". |
| Disclaimer with Predetermined Text | "PHARMA SOLUTIONS" |
| Goods and Services | Design and development of pharmaceutical, nutritional and dietary formulations; Research and development of drug delivery formulation used as facilitating agents for pharmaceutical tablets, capsules, powders, injectables, suspensions, gels, liquids; Development of pharmaceutical formulations for veterinary applications; Design and development of preparations in liquid form or solid form for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic or dietary agent; Development of particles with defined particle size dimensions and particle size distribution containing active ingredients for pharmaceutical purposes; Technology consultation in the field of pharmaceutical development |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 12, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | Friday, October 2, 2020 |
| First Use In Commerce Date | Friday, October 2, 2020 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 12, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, October 2, 2020 |
| First Use In Commerce Date | Friday, October 2, 2020 |
| Party Name | Adare Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Party Name | Adare Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Party Name | Adare Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Event Date | Event Description |
| Tuesday, March 15, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 28, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 28, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 8, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 23, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 19, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 18, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 18, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 26, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 26, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 26, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 25, 2021 | ASSIGNED TO EXAMINER |
| Saturday, February 13, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, February 12, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, December 10, 2020 | NEW APPLICATION ENTERED IN TRAM |